Pharmacelsus
German DMPK CRO offering in vitro ADME, in vivo pharmacokinetics and bioanalysis for discovery and early development.
29 contract research organizations in our directory list both Bioanalysis and Mouse among their capabilities, across 9 countries. 25 report GLP capability and 13 report AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 29 CROs. Order rotates daily so no lab is permanently listed first.
German DMPK CRO offering in vitro ADME, in vivo pharmacokinetics and bioanalysis for discovery and early development.
Bengaluru CRDMO offering discovery services including DMPK, safety and bioanalysis alongside development and manufacturing.
Global R&D services including discovery, DMPK, toxicology, bioanalysis, and manufacturing support.
Integrated CRO-CDMO in India whose discovery biology group provides in vivo pharmacology, DMPK and bioanalysis for small molecule programs.
Korean nonclinical pharmacology CRO in the Biotoxtech group offering efficacy studies, PCR-based biodistribution for cell and gene therapies, and GLP bioanalysis.
Contract testing laboratory providing GLP toxicology, analytical and bioanalytical chemistry for pharmaceutical, chemical, agrochemical, consumer and food ingredient sponsors.
St. Louis area CRO providing toxicology, pharmacokinetic and bioanalytical services, including inhalation work.
Global preclinical/clinical CRO with extensive safety assessment, pharmacology, and discovery services.
Preclinical CRO offering discovery, DMPK, toxicology, surgical models, and specialty pathology.
Large CRO with global preclinical safety assessment, DMPK, and bioanalytical services.
Preclinical oncology and immuno-oncology CRO with orthotopic and metastatic models, whole-body imaging and GLP toxicology, with sites in Australia and the US.
Preclinical GLP toxicology and safety pharmacology across small and large species.
Integrated discovery and development services company in India offering in vivo pharmacology, DMPK, bioanalysis and safety assessment alongside chemistry and biologics services.
Preclinical in vivo pharmacology and toxicology with aerosol/inhalation expertise.
Michigan CRO offering in vivo ADME and pharmacokinetics, LC-MS/MS bioanalysis and biochemistry, with a niche in ocular drug development.
German CRO offering integrated discovery, DMPK, bioanalysis and early development services across sites in Germany and France.
CRO providing DMPK, bioanalysis, toxicology, and related preclinical services.
Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.
Not-for-profit research institute in Birmingham, Alabama providing contract drug discovery and preclinical development, including infectious disease and BSL-3 work, oncology models, ADME, bioanalysis, toxicology and…
Nonclinical CRO supporting infectious disease and other in vivo studies; bioanalysis and pathology support.
Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.
Korean nonclinical CRO providing early PK, TK and bioanalytical method development and sample analysis.
Integrated CRO/CDMO spanning preclinical to early clinical, including safety assessment and bioanalysis.
Polish drug discovery CRO providing integrated chemistry, biology, DMPK and translational research services.
Australian bioanalytical and toxicology CRO with OECD GLP labs, supporting nonclinical toxicology and clinical bioanalysis.
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…